AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34657452 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay patient navigator (LPN) navigation for 6 months, including discussions on survivorship care planning and accompanying patients to primary care appointments.
Number of subjects: 40
Study 34657452 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 40
Study 33015924 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 503
Study 33015924 — intervention group
Group type: COMPARATOR
Intervention: Polypharmacy
Number of subjects: 503
Study 33165153 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal neuroimaging-based customized TMS treatment
Number of subjects: 97
Study 33165153 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal neuroimaging approaches
Number of subjects: 97
Study 36457068 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 0.2 mg/kg IV before induction of anesthesia
Number of subjects: 30
Study 36457068 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 30
Study 36457068 — intervention group
Group type: COMPARATOR
Intervention: Control group (ineffective group)
Number of subjects: 30
Study 36457068 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective group (patients with negative pain response)
Number of subjects: 30
Study 34186473 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of medications including opioids and other medications inconsistent with national (NICE) guidance
Number of subjects: 33
Study 34186473 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 33
Study 35151982 — intervention group
Group type: EXPERIMENTAL
Intervention: Action (high‐intensity stimuli) games in VR for 30 min
Number of subjects: 80
Study 35151982 — intervention group
Group type: EXPERIMENTAL
Intervention: Adventure (low‐intensity stimuli) games in VR for 30 min
Number of subjects: 80
Study 35151982 — intervention group
Group type: EXPERIMENTAL
Intervention: Videogamers
Number of subjects: 80
Study 35151982 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 80
Study 35770596 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at 2/20-25 Hz for 30 minutes at points ST36, SP6, LI4, and LR3
Number of subjects: 28
Study 35770596 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 28
Study 35770596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EA)
Number of subjects: 28
Study 35690073 — intervention group
Group type: COMPARATOR
Intervention: 3‐weekly carboplatin AUC5 or AUC6 and 3‐weekly paclitaxel 175 mg/m2 (control; group 1)
Number of subjects: 1566
Study 35690073 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐weekly carboplatin AUC5 or AUC6 and weekly paclitaxel 80 mg/m2 (group 2)
Number of subjects: 1566
Study 35690073 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly carboplatin AUC2 and weekly paclitaxel 80 mg/m2 (group 3)
Number of subjects: 1566
Study 34678909 — intervention group
Group type: EXPERIMENTAL
Intervention: Group rational-emotive behavioral education intervention (REBEI)
Number of subjects: 86
Study 34678909 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study 32170964 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (200mg then 100mg b.i.d. for 7 days)
Number of subjects: 28
Study 32170964 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (days 0-7) then Minocycline (days 7-14)
Number of subjects: 28
Study 32170964 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (days 0-7) then Placebo (days 7-14)
Number of subjects: 28
Study 32170964 — intervention group
Group type: COMPARATOR
Intervention: Initial cohort (no treatment)
Number of subjects: 28
Study 35279528 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib
Number of subjects: 124
Study 35279528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 34409927 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Rectal Examination (DRE)
Number of subjects: 270
Study 34409927 — intervention group
Group type: EXPERIMENTAL
Intervention: Free/Total PSA
Number of subjects: 270
Study 32554105 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care program
Number of subjects: 328
Study 32554105 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 328
Study 34480787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod + tPA
Number of subjects: 75
Study 34480787 — intervention group
Group type: COMPARATOR
Intervention: tPA only
Number of subjects: 75
Study 34480787 — intervention group
Group type: EXPERIMENTAL
Intervention: USPIO injection (5.6 mg/kg)
Number of subjects: 75
Study 34480787 — intervention group
Group type: EXPERIMENTAL
Intervention: USPIO injection (16.8 mg/kg)
Number of subjects: 75
Study 34480787 — intervention group
Group type: EXPERIMENTAL
Intervention: USPIO injection (56 mg/kg)
Number of subjects: 75
Study 34480787 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cortical vessels in ischemic regions
Number of subjects: 75
Study 34480787 — intervention group
Group type: COMPARATOR
Intervention: Visual cortical vessels in control regions
Number of subjects: 75
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: High-score group (GDF15, AFP, FIB-4 index scoring)
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-score group (GDF15, AFP, FIB-4 index scoring)
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-score group (GDF15, AFP, FIB-4 index scoring)
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with FIB-4 index ≤3.25
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-score group (FIB-4 index ≤3.25)
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-score group (FIB-4 index ≤3.25)
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF15 >1350 pg/mL
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: AFP >5 ng/mL
Number of subjects: 1606
Study 34812502 — intervention group
Group type: EXPERIMENTAL
Intervention: FIB-4 index >3.25
Number of subjects: 1606
Study 34904015 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Glargine
Number of subjects: 40
Study 34904015 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Detemir
Number of subjects: 40
Study 34904015 — intervention group
Group type: COMPARATOR
Intervention: Control (comparison between Glargine and Detemir)
Number of subjects: 40
Study 32858543 — intervention group
Group type: EXPERIMENTAL
Intervention: Online physical activity promotion program
Number of subjects: 26
Study 32858543 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study 32838817 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise for 8 weeks (n = 35)
Number of subjects: 66
Study 32838817 — intervention group
Group type: COMPARATOR
Intervention: Light stretching for 8 weeks (n = 31)
Number of subjects: 66
Study 32838817 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 66
Study 32901733 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone chips (group 1)
Number of subjects: 11
Study 32901733 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone chips mixed 1:1 with porcine-derived xenogenic bone (group 2)
Number of subjects: 11
Study 34800357 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature-controlled intraductal radiofrequency ablation (ID-RFA) and bilateral plastic stent (PS)
Number of subjects: 30
Study 34800357 — intervention group
Group type: COMPARATOR
Intervention: Bilateral plastic stent (PS)
Number of subjects: 30
Study 32149764 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia (group DES)
Number of subjects: 200
Study 36221414 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled silicone swelling using KF-96A-10CS oil, applied in 2 to 6 brush-coats.
Number of subjects: 24
Study 33583479 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 2919
Study 33583479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2919
Study 32559759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine sated state
Number of subjects: 30
Study 32559759 — intervention group
Group type: COMPARATOR
Intervention: Nicotine withdrawal
Number of subjects: 30
Study 32511015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy interventions for anxiety
Number of subjects: 167
Study 32511015 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 167
Study 32511015 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment accommodation
Number of subjects: 167
Study 32013901 — intervention group
Group type: EXPERIMENTAL
Intervention: School garden programme with complementary WASH, health and nutrition interventions (SG+); n=197 children
Number of subjects: 682
Study 32013901 — intervention group
Group type: COMPARATOR
Intervention: Control group; n=313 children
Number of subjects: 682
Study 35905577 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT for 8 weeks
Number of subjects: 106
Study 35905577 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 106
Study 33670508 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic contraction
Number of subjects: 16
Study 33670508 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic relaxation
Number of subjects: 16
Study 33573859 — intervention group
Group type: EXPERIMENTAL
Intervention: LUTS prevalence
Number of subjects: 2745
Study 33573859 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for LUTS presence
Number of subjects: 2745
Study 33765619 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy group (n = 17)
Number of subjects: 59
Study 33765619 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice-RT task first
Number of subjects: 59
Study 33765619 — intervention group
Group type: COMPARATOR
Intervention: No-autonomy group (n = 17)
Number of subjects: 59
Study 33765619 — intervention group
Group type: EXPERIMENTAL
Intervention: Simon task first (chosen by 9 of 17 in autonomy group)
Number of subjects: 59
Study 36008795 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofunctional treatment (MB-M group)
Number of subjects: 224
Study 36008795 — intervention group
Group type: COMPARATOR
Intervention: No treatment (MB-N group)
Number of subjects: 224
Study 36008795 — intervention group
Group type: COMPARATOR
Intervention: No treatment (NB group)
Number of subjects: 224
Study 32247194 — intervention group
Group type: EXPERIMENTAL
Intervention: Model incorporating individual symptoms and baseline characteristics
Number of subjects: 997
Study 32247194 — intervention group
Group type: COMPARATOR
Intervention: Model including early improvement in overall depression only
Number of subjects: 997
Study 35295986 — intervention group
Group type: EXPERIMENTAL
Intervention: Liothyronine 0.7 mcg/kg
Number of subjects: 12
Study 35295986 — intervention group
Group type: COMPARATOR
Intervention: Levothyroxine 0.86 mcg/kg
Number of subjects: 12
Study 35295986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 32186696 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation
Number of subjects: 0
Study 32186696 — intervention group
Group type: COMPARATOR
Intervention: Postoperative rehabilitation
Number of subjects: 0
Study 34898075 — intervention group
Group type: EXPERIMENTAL
Intervention: Linshu Decoction (1 dose bid) combined with levofloxacin (0.1 g bid)
Number of subjects: 115
Study 34898075 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin (0.1 g bid)
Number of subjects: 115
Study 36195170 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg
Number of subjects: 2485
Study 36195170 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg
Number of subjects: 2485
Study 36195170 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2485
Study 33407619 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg-interferon treatment
Number of subjects: 30
Study 32483957 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1mg/kg
Number of subjects: 90
Study 32483957 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamizole 30mg/kg
Number of subjects: 90
Study 32483957 — intervention group
Group type: COMPARATOR
Intervention: Control (no preemptive analgesia)
Number of subjects: 90
Study 32483957 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between tramadol and metamizole
Number of subjects: 90
Study 35610581 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipatory Care Planning (ACP) intervention delivered by a registered nurse including home-based patient assessment, care planning, and documentation of a support plan.
Number of subjects: 65
Study 35610581 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipatory Care Planning (ACP) intervention
Number of subjects: 65
Study 35610581 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 65
Study 32088676 — intervention group
Group type: EXPERIMENTAL
Intervention: AL-TENS
Number of subjects: 30
Study 32088676 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 30
Study 32162503 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous countermovement jumping
Number of subjects: 41
Study 32162503 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent countermovement jumping
Number of subjects: 41
Study 32162503 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 36138375 — intervention group
Group type: EXPERIMENTAL
Intervention: Health4Me text message program (4-5 messages per week for 6 months)
Number of subjects: 330
Study 36138375 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 330
Study 32651998 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Dietary Diversity Score (DDS)
Number of subjects: 7553
Study 32651998 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Prime Diet Quality Score (PDQS)
Number of subjects: 7553
Study 34301324 — intervention group
Group type: EXPERIMENTAL
Intervention: The Knack
Number of subjects: 210
Study 34301324 — intervention group
Group type: EXPERIMENTAL
Intervention: PFMT
Number of subjects: 210
Study 34301324 — intervention group
Group type: EXPERIMENTAL
Intervention: The Knack + PFMT
Number of subjects: 210
Study 32439861 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized drumming
Number of subjects: 153
Study 32439861 — intervention group
Group type: COMPARATOR
Intervention: Asynchronized drumming
Number of subjects: 153
Study 35396175 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, individualised exercise program (60-minute sessions, 2-3 sessions/week for 12 weeks)
Number of subjects: 16
Study 35396175 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program (30-minute sessions, 2-3 sessions/week for 12 weeks)
Number of subjects: 16
Study 32860843 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBP
Number of subjects: 84
Study 32860843 — intervention group
Group type: COMPARATOR
Intervention: RVOP
Number of subjects: 84
Study 32220093 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 statins (simvastatin, lovastatin, pravastatin)
Number of subjects: 284
Study 32220093 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 statins (atorvastatin, rosuvastatin)
Number of subjects: 284
Study 32220093 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 284
Study 32694287 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training and ankle mobility program (n = 11)
Number of subjects: 20
Study 32694287 — intervention group
Group type: COMPARATOR
Intervention: Strength training only (n = 9)
Number of subjects: 20
Study 33657337 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire to feel better and have more energy
Number of subjects: 322
Study 33657337 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire to maintain health
Number of subjects: 322
Study 33657337 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate routine physical activity levels
Number of subjects: 322
Study 33657337 — intervention group
Group type: EXPERIMENTAL
Intervention: High routine physical activity levels
Number of subjects: 322
Study 33657337 — intervention group
Group type: EXPERIMENTAL
Intervention: Busy lifestyle as a barrier
Number of subjects: 322
Study 32745598 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Focused Therapy for High-Risk Youth (FFT-HR)
Number of subjects: 34
Study 32745598 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care (EC)
Number of subjects: 34
Study 35581710 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 60
Study 35581710 — intervention group
Group type: COMPARATOR
Intervention: Transversus abdominis plane (TAP) block
Number of subjects: 60
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model combining clinical features and multi-scale histopathologic and radiomic image features
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical features only
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) only
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathological images only
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI plus pathology
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI plus clinical
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathology plus clinical
Number of subjects: 109
Study 33725579 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of clinical, MRI, and pathology features
Number of subjects: 109
Study 36306175 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus exercise
Number of subjects: 204
Study 36306175 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 204
Study 36306175 — intervention group
Group type: COMPARATOR
Intervention: Wait and see
Number of subjects: 204
Study 32938875 — intervention group
Group type: COMPARATOR
Intervention: 11 English-language symptom checkers
Number of subjects: 574
Study 32938875 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual patient encounters
Number of subjects: 574
Study 35589134 — intervention group
Group type: EXPERIMENTAL
Intervention: CLO view (60°±5°)
Number of subjects: 79
Study 35589134 — intervention group
Group type: COMPARATOR
Intervention: LAT view
Number of subjects: 79
Study 32402630 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT) combined with rehabilitation exercise
Number of subjects: 109
Study 32402630 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 109
Study 32402630 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CDT and Control)
Number of subjects: 109
Study 33272841 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-duration high-intensity exercise (HIE) for 20 min at 70%–80% heart rate reserve (HRR)
Number of subjects: 42
Study 33272841 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-duration low-intensity exercise (LIE) for 60 min at 30%–40% HRR
Number of subjects: 42
Study 33079070 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital therapeutic intervention plus usual care
Number of subjects: 50
Study 33079070 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 50
Study 35659695 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal process-based CBT intervention (six sessions)
Number of subjects: 604
Study 35659695 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 604
Study 34937145 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (200 mg on day 1 and 100 mg on days 2 and 3)
Number of subjects: 562
Study 34937145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study 34937145 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 562
Study 32278106 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Suture Group
Number of subjects: 183
Study 32278106 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted Cutaneous Suture Group
Number of subjects: 183
Study 32278106 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted Subcutaneous Suture Group
Number of subjects: 183
Study 32278106 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 183
Study 34487147 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pylorus-preserving gastrectomy (LPPG)
Number of subjects: 256
Study 34487147 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic distal gastrectomy (LDG)
Number of subjects: 256
Study 34487147 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LPPG and LDG)
Number of subjects: 256
Study 33159033 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (IN‐OT) treatment (24 IU daily for 4 weeks)
Number of subjects: 38
Study 33159033 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose IN‐OT treatment (24 IU daily for 4 weeks)
Number of subjects: 38
Study 33159033 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study 32991355 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg/d
Number of subjects: 96
Study 32991355 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 96
Study 32814339 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT) for 3 months, 3 times per week on a GalileoTM vibration plate at 6-20 Hz
Number of subjects: 26
Study 32814339 — intervention group
Group type: COMPARATOR
Intervention: Control training group (CTG) performing sham WBV training
Number of subjects: 26
Study 32978034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition for Learning and for Understanding Everyday Social Situations (CLUES)
Number of subjects: 38